Klimik Dergisi, cilt.38, sa.2, ss.1-9, 2025 (ESCI)
This consensus report presents current expert opinions on the clinical use of the BioFire® FilmArray® Pneumonia Plus (PNplus) rapid molecular test in patients with pneumonia. A group of eight physicians with clinical experience in pneumonia identified common questions encountered in clinical practice regarding the use of PNplus for lower respiratory tract infections and developed consensus-based answers. Based on this process, a list of recommendations was compiled for the use of the PNplus rapid syndromic molecular test, which detects the most common bacteria, viruses, and resistance genes. These recommendations were supported by case examples based on fictional clinical scenarios, along with a proposed diagnostic algorithm for the management of pneumonia.